Zimmer Biomet Holdings (($ZBH)) announced an update on their ongoing clinical study. The Persona OsseoTi Keel Compatibility Study, officially ...

-- New Porous Iteration of Anatomic Keeled Tibia Designed to Deliver Stable Initial and Biological Fixation Together with the Clinically Proven Benefits of the Persona Knee System -- WARSAW, Ind., Nov ...

Zimmer Biomet Holdings (($ZBH)) announced an update on their ongoing clinical study. Study Overview: Zimmer Biomet Holdings is conducting the ...

WARSAW, Ind., and ZURICH, Nov. 18, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (ZBH), a global medical technology leader, today received the CE Mark for its Persona® Revision Knee System. This ...

Detailed price information for Zimmer Biomet Holdings (ZBH-N) from The Globe and Mail including charting and trades.

Zimmer Biomet Holdings, Inc. ZBH recently received the FDA 510(k) clearance for its Persona SoluTion Porous Plasma Spray (“PPS”) Femur. Persona SoluTion PPS Femur is a total knee implant component ...

WARSAW, Ind., Dec. 4, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of Persona ® ...

"After the successful introduction of Persona Revision Knee in the United States and other markets, the CE Mark certification and commercial launch extends its availability significantly so that more ...